AIIMS New Delhi partners with MediSim VR to advance VR skill training in medical education
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
Subscribe To Our Newsletter & Stay Updated